Articles

Gilead Sciences and Satcher Health Leadership Institute study COVID-19 racial health inequities

Researchers will create a data map to systematically address the impact of COVID-19 on Black and minority communities
Brought to you byDDNews Staff
| 2 min read

FOSTER CITY, Calif. & ATLANTA—Gilead Sciences, Inc. and the Satcher Health Leadership Institute at the Morehouse School of Medicine are working together to develop a real-time, public-facing, comprehensive health equity data platform. The platform will help address the impact of COVID-19 and other diseases on communities of color.

“As we have seen, COVID-19 is magnifying inequities that predate the pandemic,” said Daniel E. Dawes, director of the Satcher Health Leadership Institute. “Black Americans, Native Americans, Latinx Americans, Asian and Pacific Islander Americans still contend with neighborhoods that are largely devoid of health-sustaining and health-protective resources, and they still contend with the political determinants or drivers that created, perpetuated and exacerbated these health inequities.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A researcher wearing a white lab coat and blue nitrile glove holds a tiny brown glass sample vial with a blue cap in front of an autosampler carousel on a HPLC laboratory analyzer.
Hear an expert perspective on the hidden variables affecting chromatographic methods and how to build more robust, reliable workflows.
Researcher using a laptop with a digital DNA helix and molecular biology graphics overlaid, illustrating connected workflows for sequence design, data management, and therapeutic research.
To keep pace with modern drug discovery, researchers need molecular biology approaches that can support complexity without slowing down the science.
Shaping Science graphic featuring the question “How can labs become truly sustainable?” and a photo of James Connelly, Chief Executive Officer of My Green Lab.
Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.